A previous study has reported that serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities, which proved larger waists, where the thickness of subcutaneous fat exceeds visceral fat, are predictors of levels of serum Lp(a) [27]. This evidence concerns the gene LPA and metabolic dysfunction-associated steatotic liver disease.